NATional TUnisian REgistry of Atrial Fibrillation

Launched by DACIMA CONSULTING · Mar 14, 2017

Keywords

ClinConnect Summary

The NATURE-AF study is carried out in Tunisia at cardiology consultations in hospitals and in the liberal sector. A total of 91 cardiologists participate in the selection of patients as investigators. The study is a longitudinal non-interventional registry of atrial fibrillation. The data collected are managed by the DACIMA Clinical Suite® platform, which complies with international standards: FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPPA (Health Insurance Portability and Accountability Act), ICH (International Conference on Harmonisation), ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • At least one episode of atrial fibrillation, documented on a 12-lead ECG and / or a rhythmic holter (duration of the episode: 30 seconds or more)
• • Recent atrial fibrillation diagnosed for less than a year
• • Regular monitoring every 3 months is ensured
• • Informed, read and signed consent
• Exclusion Criteria:
• • Estimated life expectancy at less than 12 months
• • Transient atrial fibrillation due to reversible cause (eg acute myocardial infarction, following cardiac surgery, acute alcohol intoxication, hyperthyroidism, pulmonary embolism or other acute pulmonary disease, pericarditis, myocarditis, hydro-electrolyte disorder, metabolic disorder)
• • Cardiac surgery ≤ 3 months
• • Atrial flutter isolated without atrial fibrillation
• • Mental disorders
• • Ongoing anticoagulation for reasons other than atrial fibrillation